Connor, Clark & Lunn Investment Management (CC&L)’s Enzo Biochem, Inc. ENZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-64,109
| Closed | -$144K | – | 1157 |
|
|
2020
Q2 | $144K | Buy |
64,109
+39,563
| +161% | +$88.9K | ﹤0.01% | 929 |
|
|
2020
Q1 | $62K | Buy |
+24,546
| New | +$62K | ﹤0.01% | 961 |
|
|
2019
Q4 | – | Sell |
-11,175
| Closed | -$40K | – | 1120 |
|
|
2019
Q3 | $40K | Buy |
+11,175
| New | +$40K | ﹤0.01% | 938 |
|
|
2017
Q3 | – | Sell |
-20,820
| Closed | -$230K | – | 936 |
|
|
2017
Q2 | $230K | Sell |
20,820
-11,900
| -36% | -$131K | ﹤0.01% | 716 |
|
|
2017
Q1 | $274K | Buy |
32,720
+1,700
| +5% | +$14.2K | ﹤0.01% | 748 |
|
|
2016
Q4 | $215K | Sell |
31,020
-8,100
| -21% | -$56.1K | ﹤0.01% | 777 |
|
|
2016
Q3 | $199K | Sell |
39,120
-19,100
| -33% | -$97.2K | ﹤0.01% | 733 |
|
|
2016
Q2 | $348K | Sell |
58,220
-62,600
| -52% | -$374K | ﹤0.01% | 651 |
|
|
2016
Q1 | $550K | Sell |
120,820
-17,400
| -13% | -$79.2K | ﹤0.01% | 553 |
|
|
2015
Q4 | $622K | Buy |
138,220
+23,800
| +21% | +$107K | 0.01% | 512 |
|
|
2015
Q3 | $363K | Buy |
114,420
+22,100
| +24% | +$70.1K | ﹤0.01% | 573 |
|
|
2015
Q2 | $280K | Buy |
92,320
+700
| +0.8% | +$2.12K | ﹤0.01% | 507 |
|
|
2015
Q1 | $270K | Buy |
91,620
+12,100
| +15% | +$35.7K | ﹤0.01% | 468 |
|
|
2014
Q4 | $353K | Buy |
79,520
+6,100
| +8% | +$27.1K | ﹤0.01% | 439 |
|
|
2014
Q3 | $378K | Buy |
+73,420
| New | +$378K | ﹤0.01% | 423 |
|